tiprankstipranks
Trending News
More News >
Beijing Tong Ren Tang Chinese Medicine Co (HK:3613)
:3613
Hong Kong Market

Beijing Tong Ren Tang Chinese Medicine Co (3613) Ratios

Compare
1 Followers

Beijing Tong Ren Tang Chinese Medicine Co Ratios

HK:3613's free cash flow for Q4 2024 was HK$0.65. For the 2024 fiscal year, HK:3613's free cash flow was decreased by HK$ and operating cash flow was HK$0.33. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.80 11.65 8.80 15.38 13.54
Quick Ratio
7.68 8.59 7.68 13.35 11.25
Cash Ratio
4.76 3.03 4.76 7.79 6.58
Solvency Ratio
1.48 1.51 1.48 2.29 2.16
Operating Cash Flow Ratio
1.31 1.40 1.31 3.65 0.54
Short-Term Operating Cash Flow Coverage
2.50K 2.78K 2.50K 1.62K 446.36
Net Current Asset Value
HK$ 3.20BHK$ 3.43BHK$ 3.20BHK$ 2.98BHK$ 2.65B
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.03 0.02 0.03 0.03
Debt-to-Equity Ratio
0.03 0.03 0.03 0.04 0.04
Debt-to-Capital Ratio
0.03 0.03 0.03 0.04 0.03
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.17 1.15 1.17 1.12 1.13
Debt Service Coverage Ratio
158.39 111.06 158.39 139.96 142.79
Interest Coverage Ratio
174.12 104.41 174.12 165.38 155.68
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.13 0.16 0.13 0.16 0.13
Net Debt to EBITDA
-2.08 -1.11 -2.08 -1.80 -1.72
Profitability Margins
Gross Profit Margin
66.44%68.67%66.44%71.95%72.45%
EBIT Margin
47.98%45.49%47.98%50.32%52.47%
EBITDA Margin
52.43%51.12%52.43%54.80%58.47%
Operating Profit Margin
46.88%40.93%46.88%50.02%50.89%
Pretax Profit Margin
47.71%45.10%47.71%50.02%52.15%
Net Profit Margin
37.31%35.44%37.31%39.06%41.24%
Continuous Operations Profit Margin
40.02%38.73%40.02%41.85%43.24%
Net Income Per EBT
78.20%78.57%78.20%78.09%79.09%
EBT Per EBIT
101.77%110.20%101.77%99.99%102.46%
Return on Assets (ROA)
15.29%12.19%15.29%15.85%15.88%
Return on Equity (ROE)
17.92%13.98%17.92%17.78%17.98%
Return on Capital Employed (ROCE)
21.32%15.21%21.32%21.49%20.92%
Return on Invested Capital (ROIC)
17.65%12.88%17.65%17.73%17.10%
Return on Tangible Assets
15.51%12.34%15.51%16.11%16.13%
Earnings Yield
6.73%5.25%6.73%5.41%7.95%
Efficiency Ratios
Receivables Turnover
1.88 3.61 1.88 2.95 2.41
Payables Turnover
3.78 2.70 3.78 12.62 4.89
Inventory Turnover
1.24 0.47 1.24 1.01 0.73
Fixed Asset Turnover
4.27 3.49 4.27 3.78 3.35
Asset Turnover
0.41 0.34 0.41 0.41 0.38
Working Capital Turnover Ratio
0.55 0.45 0.55 0.54 0.52
Cash Conversion Cycle
393.25 739.00 393.25 455.88 575.86
Days of Sales Outstanding
194.66 101.24 194.66 123.71 151.64
Days of Inventory Outstanding
295.15 772.98 295.15 361.10 498.87
Days of Payables Outstanding
96.57 135.22 96.57 28.93 74.65
Operating Cycle
489.82 874.22 489.82 484.81 650.51
Cash Flow Ratios
Operating Cash Flow Per Share
0.65 0.55 0.65 0.93 0.14
Free Cash Flow Per Share
0.61 0.52 0.61 0.90 0.12
CapEx Per Share
0.05 0.03 0.05 0.03 0.02
Free Cash Flow to Operating Cash Flow
0.93 0.95 0.93 0.97 0.89
Dividend Paid and CapEx Coverage Ratio
1.14 1.55 1.14 3.46 0.56
Capital Expenditure Coverage Ratio
14.22 21.08 14.22 33.17 9.01
Operating Cash Flow Coverage Ratio
5.31 3.50 5.31 6.05 1.09
Operating Cash Flow to Sales Ratio
0.32 0.30 0.32 0.50 0.09
Free Cash Flow Yield
5.31%4.26%5.31%6.71%1.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.85 19.05 14.85 18.48 12.58
Price-to-Sales (P/S) Ratio
5.54 6.75 5.54 7.22 5.19
Price-to-Book (P/B) Ratio
2.66 2.66 2.66 3.29 2.26
Price-to-Free Cash Flow (P/FCF) Ratio
18.85 23.46 18.85 14.90 66.12
Price-to-Operating Cash Flow Ratio
17.52 22.34 17.52 14.45 58.79
Price-to-Earnings Growth (PEG) Ratio
2.71 -1.22 2.71 1.50 -8.30
Price-to-Fair Value
2.66 2.66 2.66 3.29 2.26
Enterprise Value Multiple
8.49 12.09 8.49 11.38 7.15
Enterprise Value
7.71B 9.43B 7.71B 9.70B 5.50B
EV to EBITDA
8.49 12.09 8.49 11.38 7.15
EV to Sales
4.45 6.18 4.45 6.23 4.18
EV to Free Cash Flow
15.14 21.48 15.14 12.87 53.33
EV to Operating Cash Flow
14.08 20.46 14.08 12.48 47.41
Tangible Book Value Per Share
4.40 4.74 4.40 4.16 3.67
Shareholders’ Equity Per Share
4.31 4.62 4.31 4.08 3.60
Tax and Other Ratios
Effective Tax Rate
0.16 0.14 0.16 0.16 0.17
Revenue Per Share
2.07 1.82 2.07 1.86 1.57
Net Income Per Share
0.77 0.65 0.77 0.73 0.65
Tax Burden
0.78 0.79 0.78 0.78 0.79
Interest Burden
0.99 0.99 0.99 0.99 0.99
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.09 0.12 0.09 0.10 0.11
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.66 0.85 0.66 1.00 0.17
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis